Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Cytokines in alcoholic liver disease.

An L, Wang X, Cederbaum AI.

Arch Toxicol. 2012 Sep;86(9):1337-48. doi: 10.1007/s00204-012-0814-6. Epub 2012 Feb 25. Review.

PMID:
22367091
2.

The role of cytokines in non-alcoholic fatty liver disease.

Tilg H.

Dig Dis. 2010;28(1):179-85. doi: 10.1159/000282083. Epub 2010 May 7. Review.

PMID:
20460908
3.
4.

Adiponectin and alcoholic fatty liver disease.

Rogers CQ, Ajmo JM, You M.

IUBMB Life. 2008 Dec;60(12):790-7. doi: 10.1002/iub.124. Review.

5.

Regulation of Kupffer cell activity during chronic ethanol exposure: role of adiponectin.

Park PH, Thakur V, Pritchard MT, McMullen MR, Nagy LE.

J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S30-3. Review.

PMID:
16958668
6.

Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease.

McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I.

Am J Physiol Gastrointest Liver Physiol. 2004 Sep;287(3):G497-502. Review.

7.

Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.

Sakaguchi S, Takahashi S, Sasaki T, Kumagai T, Nagata K.

Drug Metab Pharmacokinet. 2011;26(1):30-46. Epub 2010 Dec 7. Review.

8.

Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue.

Lin HZ, Yang SQ, Zeldin G, Diehl AM.

Alcohol Clin Exp Res. 1998 Aug;22(5 Suppl):231S-237S.

PMID:
9727642
9.

Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease.

McClain C, Barve S, Joshi-Barve S, Song Z, Deaciuc I, Chen T, Hill D.

Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):180S-8S. Review.

PMID:
16344606
10.

Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity.

Nath B, Szabo G.

Semin Liver Dis. 2009 May;29(2):166-77. doi: 10.1055/s-0029-1214372. Epub 2009 Apr 22. Review.

PMID:
19387916
11.

Cytokines in alcoholic liver disease.

McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D.

Semin Liver Dis. 1999;19(2):205-19. Review.

PMID:
10422201
12.

Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease.

Kamimura S, Tsukamoto H.

Hepatology. 1995 Oct;22(4 Pt 1):1304-9.

PMID:
7557885
13.

The effect of inflammatory cytokines in alcoholic liver disease.

Kawaratani H, Tsujimoto T, Douhara A, Takaya H, Moriya K, Namisaki T, Noguchi R, Yoshiji H, Fujimoto M, Fukui H.

Mediators Inflamm. 2013;2013:495156. doi: 10.1155/2013/495156. Epub 2013 Dec 9. Review.

14.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

15.

Adiponectin: key player in the adipose tissue-liver crosstalk.

Moschen AR, Wieser V, Tilg H.

Curr Med Chem. 2012;19(32):5467-73. Review.

PMID:
22876924
16.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
17.

Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis.

Hu S, Yin S, Jiang X, Huang D, Shen G.

Eur J Pharmacol. 2009 Aug 15;616(1-3):287-92. doi: 10.1016/j.ejphar.2009.06.044. Epub 2009 Jul 2.

PMID:
19576882
18.

Glycine regulates the production of pro-inflammatory cytokines in lean and monosodium glutamate-obese mice.

Alarcon-Aguilar FJ, Almanza-Perez J, Blancas G, Angeles S, Garcia-Macedo R, Roman R, Cruz M.

Eur J Pharmacol. 2008 Dec 3;599(1-3):152-8. doi: 10.1016/j.ejphar.2008.09.047. Epub 2008 Oct 9.

PMID:
18930730
20.

Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease.

Gao B.

J Gastroenterol Hepatol. 2012 Mar;27 Suppl 2:89-93. doi: 10.1111/j.1440-1746.2011.07003.x. Review.

Supplemental Content

Support Center